I. INTRODUCTION
The most active vitamin D 3 metabolite 1α,25-dihydroxyvitamin D 3 (1,25(OH) 2 
II. WNT SIGNALING
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TCF2/LEF1, TCF3 and TCF4) family of transcription factors ( Figure 1B ). TCF/LEFs bind to specific DNA sequences referred to as Wnt responsive elements (WRE: CCTTTGA/TA/T).
In the absence of Wnt signals, TCF/LEF proteins are mostly repressors although in some cases they may activate transcription of their target genes. TCF/LEFs repress gene expression by interacting with corepressors such as Groucho/TLE1, which promotes histone deacetylation and chromatin compaction ( Figure 1A ). Binding of β-catenin to TCF/LEFs displace corepressors [10] and recruits a plethora of coactivators which trigger transcriptional activation of TCF/LEF-bound genes that were previously repressed ( Figure 1B ). β-Cateninassociated coactivators include BCL9 and Pygo, Mediator complex, p300/CBP and TRRAP/TIP60 histone acetyltransferases (HATs), MLL1/2 histone metyltransferases (HMTs), the SWI/SNF family of ATPases for chromatin remodelling, telomerase, and the PAF1 complex for transcription elongation and histone modification [11] [12] [13] . Intriguingly, recent evidence suggests that during Wnt-induced transcription β-catenin and its coactivators cycle on and off the WRE with a 60 min periodicity and are replaced by Groucho/TLE1 [3, 14, 15] . Recently also, APC has been found to antagonize -catenin/TCF-dependent transcription by promoting the exchange of coactivators with corepressors within the nucleus in a stepwise and oscillating manner [14] . Thus, both coactivators and corepressors appear to be active during β-catenin-mediated transcription.
PLEASE, INSERT FIGURE 1 HERE
Numerous β-catenin/TCF or Wnt target genes have been identified in diverse biological systems and they are mostly cell-and context-specific [16] . Products of Wnt target genes have a large variety of biochemical functions including cell cycle kinase regulation, cell adhesion, hormone signaling, and transcription regulation. The plurality and diversity of these biochemical functions reflect the variety of different biological effects of the Wnt pathway, including activation of cell cycle progression and proliferation, inhibition of 6 apoptosis, and regulation of embryonic development and cell differentiation, growth and migration [16] . For a comprehensive, updated overview of β-catenin/TCF target genes, we recommend Roel Nusse´s Wnt homepage (http://www.stanford.edu/~rnusse/wntwindow.html).
Deregulation or abnormal activation in adult life of the Wnt/β-catenin signaling pathway contributes to the emergence and progression of several types of human cancer. This is not surprising as the Wnt1 gene (Int1 was its first name) was discovered in mouse mammary carcinomas as a target of insertional activation by the mouse mammary tumor virus [17] . Cancer cells with mutationally activated Wnt pathway overexpress at least 20
target genes that activate proliferation including proto-oncogenes c-MYC, c-JUN, and CCND1/cyclin D1 [16] .
B. Non-Canonical Wnt Pathways
Non-canonical Wnt pathways are very diverse and are still evolving into an increasing number of branches [18] . Among them, Wnt/planar cell polarity (PCP) and Wnt/calcium pathways are relatively better characterized.
The Wnt/PCP pathway was described in Drosophila melanogaster. It regulates the polarity of epithelial cells within the plane of the epithelium, e.g. orienting Drosophila wing hairs or regulating the organization of the ommatidia in the fly eye [19] . In vertebrates, a similar pathway has been described regulating convergent extension movements during gastrulation or neurulation and migration of neural crest cells [20] [21] [22] The Wnt/-catenin pathway is the main driving force behind the proliferation of epithelial cells in the colonic crypts and functional studies have confirmed that this pathway 9 constitutes the master switch between proliferation and differentiation of the epithelial cells [57, 58] . Thus, active Wnt signaling is essential for the maintenance of crypt progenitor compartments in the intestine. This is evidenced by mice lacking the Tcf4 transcription factor [59] , by the conditional depletion of -catenin from the intestinal epithelium [60, 61] , and by transgenic inhibition of extracellular Wnt signaling through Dkk-1 [62, 63] . In all cases, a dramatic reduction of proliferative activity was observed. In the converse experiment, activating the Wnt pathway through transgenic expression of the Wnt agonist R-Spondin-1 resulted in a massive hyperproliferation of intestinal crypts [64] .
Although Wnt signaling is essential to the normal physiology of the intestine, it was first characterized by its association with colorectal cancer, one of the most common cancers in industrialized countries. Fearon and Vogelstein [65] [72] . Second, 1,25(OH) 2 D 3 induces β-catenin nuclear export and relocation to the plasma membrane adherens junctions. As β-catenin is no longer in the nucleus, transcription of TCF/LEF target genes is halted ( Figure 3B ). This happens concomitantly to an increase in Ecadherin protein expression. 1,25(OH) 2 D 3 induction of E-cadherin in SW480-ADH human colon cancer cells was observed soon after treatment and peaked at 48-72 h, and correlated with a change to a more differentiated phenotype [72] . Thus, 1,25(OH) 2 D 3 may cause a reduction in nuclear β-catenin concentration by promoting its sequestration at the adherens junctions bound to the newly synthesized E-cadherin ( Figure 3B ). Alternatively, 1,25(OH) 2 D 3 might stimulate β-catenin nuclear export through yet unknown mechanisms.
Although APC has been proposed as a contributor to -catenin nuclear export [73] , the relocation of -catenin takes place in SW480-ADH cells that express a truncated APC protein.
We have shown that transient activation of the RhoA small GTPase is necessary for the induction by 1,25(OH) 2 D 3 of the expression of CDH1/E-cadherin and many other genes in several cell types [74] . Interestingly, RhoA activity is also required for the promotion of -catenin nuclear export and for the inhibition of -catenin/TCF4 transcriptional activity and cell proliferation [74] , suggesting a relationship between E-cadherin expression and nuclear export. Moreover, it is worth noticing that although the export of β-catenin out of the nucleus contributes to the inhibition of β-catenin/TCF4-mediated transcriptional activity in some cell lines, the global antagonism of 1,25(OH) 2 D 3 on this signaling pathway must be independent of E-cadherin induction, as it takes places in LS-174T colon cancer cells that lack E-cadherin expression [72] .
In addition to 1,25(OH) 2 D 3 , the vitamin D analogues EB1089, MC903 and KH1060 [72] and the superagonistic fluorinated CD578, WU515 and WY113 compounds [75] also inhibit -catenin/TCF transcriptional activity in a strictly VDR-dependent fashion, as inhibition does not occur in SW480-R or SW620 cells that lack VDR expression. Moreover, the transcription factors SNAIL1 and SNAIL2 (also called SLUG), which repress VDR expression [76, 77] , abolish this effect in vitro and in vivo [77, 78] .
These results indicate that 1,25(OH) 2 D 3 downregulates the Wnt/β-catenin signaling pathway, and may thus control the phenotype of colon epithelial cells. Upon -catenin stabilization in colon cancer cells due to its own mutation or that of APC or AXIN2, binding to VDR may buffer its stimulatory action on TCF4 target genes, a protective effect which can be lost along with VDR expression during malignant progression linked to SNAIL1/SNAIL2 upregulation. Additionally, we found that nuclear β-catenin transiently potentiates VDR transcriptional activity before -catenin moves out of the nucleus and/or VDR is extinguished [72] .
Shah and cols. [79] confirmed and extended the finding of VDR/β-catenin interaction.
These authors have characterized the interacting domains in VDR and -catenin: the activator function-2 (AF-2) domain of VDR and the C-terminal region of β-catenin.
Moreover, they showed that acetylation of β-catenin C-terminal region differentially regulates its ability to activate TCF/LEF or VDR-regulated promoters. The mutation of a specific residue in the AF-2 domain, which renders a VDR that can bind hormone but is transcriptionally inactive in the context of classical coactivators, still allows interaction with β-catenin and ligand-dependent activation of VDRE-containing promoters. Interestingly, VDR antagonists, which block the recruitment by VDR of classical coactivators, do allow VDR to interact with β-catenin, suggesting that some ligands would permit those functions of VDR that involve β-catenin interaction [79] . In addition to human colon cancer cells, the inhibition of -catenin/TCF transcriptional activity by 1,25(OH) 2 D 3 or its analogues QW and BTW has been found in rat Rama 37 mammary cells [80] . Nuclear hormone receptors other than VDR have also been reported to regulate -catenin transcriptional activity in several types of cells and tissues, reflecting a complex crosstalk between hormonal systems and Wnt signaling [82, 83] .
Notably, a novel mechanism of Wnt/-catenin signaling pathway inhibition by 1,25(OH) 2 D 3 has recently been reported by Kaler and cols. [84] . These authors have shown that THP-1 macrophages activate the Wnt/-catenin signaling pathway in HCT116 and Hke-3 colon carcinoma cells via the STAT-1-mediated production and secretion of interleukin (IL)-1, which blocks GSK3 activity and hence increases -catenin/TCF transcriptional activity and proliferation of carcinoma cells ( Figure 3D ). This mechanism, which might contribute to the tumorigenic effect of tumor-associated macrophages in vivo, is repressed by 1,25(OH) 2 D 3 through the inhibition of the constitutive activation of STAT-1 and the production of IL-1 in macrophages [84] ( Figure 3D ). Additionally, LRP5/6 may have -catenin-independent effects under the control of DKK-1 [91] . These data indicate that DKK-1 can inhibit tumorigenesis by different mechanisms and that its induction might be of unforeseen importance for the anticancer action of 1,25(OH) 2 D 3 .
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We and others have observed that, in addition to 1,25(OH) 2 D 3 , the transcription of the DKK-1 gene is enhanced by β-catenin/TCF itself acting on several sites in the promoter region [92] [93] [94] . Our group also reported the downregulation of DKK-1 in human colon cancer [93] indicating the loss of this negative feedback control of the Wnt/β-catenin pathway in this neoplasia. Reduced DKK-1 expression is due, at least in part, to promoter methylation, which is specifically found in 25% of advanced, less differentiated tumors (Dukes' stages C and D)
[89]. Thus, the induction of DKK-1 expression by 1,25(OH) 2 D 3 may restore DKK-1 antitumoral effects in those colon tumors in which DKK-1 downregulation is not due to promoter methylation. The finding that DKK-1 expression is silenced in dedifferentiated colorectal tumors and the association of DKK-1 expression with the differentiated phenotype suggests that DKK-1 accumulation is not only concomitant with, but also plays an active role in the differentiation process. Accordingly, we have also demonstrated a significant correlation between the expression of VDR and DKK-1 in human colon cancer [85] . VDR is considered a marker of differentiation in this neoplasia [95, 96] Moreover, DKK-4 RNA levels are already increased in patients with inflammatory bowel disease [105, 106] . These results contrast with the common silencing of the DKK-4 gene in colon cancer cell lines that we and others [107] have found and that may be related to cell culture conditions. They also contrast with results from Baehs and cols. [113] . Also, recent data show that TCF4 expression is lost in human breast cancers but abundant in the surrounding normal tissue, indicating that TCF4 might be a tumor suppressor in this tissue [114] . Consequently, it is possible that the 1,25(OH) 2 D 3 /VDR-mediated increase in TCF4 may have a protective role in colon and breast cancer.
IV. WNT AND 1,25(OH) 2 D 3 IN THE BONE
A. Wnt Signaling and Bone Homeostasis
The observation that Wnt signaling is critical in bone biology has been a major development in the area over the past few years. Bone marrow-derived mesenchymal stem cells (BMSCs)
can potentially differentiate into adipocytes, chondrocytes, or osteoblasts. Although the precise orchestration of Wnt signaling during bone development is dependent on complex microenvironmental cues, data from several groups suggest that Wnt signaling is central to osteoblastogenesis while it represses differentiation of BMSCs to alternative cell types, such as adipocytes [115, 116] . A number of different Wnt proteins play a role in bone formation.
Wnt10b
-/-mice have decreased trabecular bone and serum osteocalcin [117] , while transgenic mice that express Wnt10b in bone marrow show increased bone mass and strength [117] . The expression of Wnt10b in mesenchymal progenitors induced the expression of Runx2 and Osterix, two transcription factors associated with osteoblast differentiation, and stimulated osteoblastogenesis [117] . Likewise, Wnt3a +/-and Wnt5a +/-mice showed a decrease in bone mass [118] which associates with a reduced number of osteoblasts. Wnt5a does not activate Wnt/β-catenin signaling but a non-canonical pathway, and has been shown to induce osteoblastogenesis by inactivation of peroxisome proliferator-activated receptor-γ (PPARγ), a key adipogenic transcription factor, and activation of Runx2 [118] . Thus both canonical and non-canonical Wnt signaling pathways play a role in osteoblast differentiation and bone formation.
The involvement of Wnt/β-catenin signaling in the control of bone biology is further supported by findings related to the LRP5 gene. Loss-of-function mutations in this gene were associated with low bone mass in the osteoporosis pseudoglioma syndrome (OPPG, [119] ), whereas a single amino-acid substitution (G171V) in the same gene was associated with a high bone mass state in two kindreds [120, 121] . This mutation inhibits the ability of DKK-1 and potentially other proteins to bind to LRP5 and inhibit Wnt signaling. In line with this, mice with disruption of Lrp5 in all cells, similar to patients with OPPG, have a low bone mass phenotype which is secondary to reduced osteoblast proliferation [122] .
Recently, Yadav and cols. [123] have demonstrated that Lrp5 has an important role inhibiting serotonin biosynthesis in the gut. Serotonin had previously been implicated in the regulation of bone mass [124] and gut-specific deletion of Lrp5 was shown to result in a low bone mass phenotype [123] . In contrast, osteoblast-specific deletion of Lrp5 did not cause a similar defect. Thus, bone formation appears to be controlled by Lrp5-mediated serotonin inhibition in the intestine. It is possible that LRP6, rather than LRP5, is the critical coreceptor for Wnt signaling in bone. Consistent with this, the Lrp6 loss of function bone phenotype is much more severe than the Lrp5 loss of function phenotype. Although Lrp6 -/-mice die at birth [125] , Lrp6 heterozygous mice display reduced bone mass [126] . In this regard, a missense mutation in LRP6 that resulted in impaired Wnt signaling was reported in a family with autosomal dominant early coronary artery disease, metabolic risk factors, and osteoporosis [127] .
Wnt extracellular inhibitors also have a relevant role in bone biology. Dkk-1 overexpression in transgenic mice resulted in severe osteopenia with a 49% reduction in the number of osteoblasts [128] . In contrast, mice engineered to lack Dkk-1 showed increased bone formation and bone mass [129] . In humans, elevated expression of DKK-1 in myeloma patients has been associated with bone disease [130] .
SFRP1 has also been identified as a regulator of osteoblast and osteocyte survival, with effects on trabecular bone mass. Expression of SFRP1 increases with advancing osteoblast differentiation and peak expression of SFRP1 occurs at the pre-osteocyte stage [131] . Mechanistically, deletion of Sfrp1 in mice led to a decrease in osteoblast and osteocyte apoptosis with a resultant increase in osteocyte number in vivo [132] .
The Wnt inhibitor Sclerostin, product of the SOST (SclerOSTeosis) gene, also has a critical role in the control of bone mass. Sclerostin is produced exclusively by osteocytes and inhibits bone formation. Inactivating mutations in SOST result in sclerosteosis, a sclerosing bone dysplasia [133, 134] . Targeted deletion of the Sost gene in mice results in increased bone formation and strength [135] ; conversely transgenic mice overexpressing Sost have low bone mass [136] .
In summary, activation of the Wnt/β-catenin pathway leads to increased bone mass while suppression results in bone loss.
B. 1,25(OH) 2 D 3 Promotes Wnt/β-Catenin Signaling in Osteoblasts
The important role of 1,25(OH) 2 D 3 in bone homeostasis is well known (See chapters "Development of the Skeleton", "Osteoblasts" and "Osteoclasts"). The function of VDR in 20 osteoblasts seems to be modulated as a function of the differentiation stage of the cells.
Indeed, calvarial osteoblasts from Vdr null mice displayed enhanced osteogenesis in vitro,
suggesting that VDR activation in pre-osteoblasts suppresses bone formation [137] , whereas the expression of a Vdr transgene in mature osteoblasts results in increased bone mass [138] .
This differentiation-dependent effect may however be species-specific, as it is not observed in humans ( [141] while it represses the SOST homologue WISE/SOSTDC1 gene in keratinocytes [142] . Similarly, Dkk-1 expression is inhibited by 1,25(OH) 2 D 3 in BMSCs while it is induced by the hormone in colon cancer cells [85, 140] ( Figure 4 ).
V. WNT AND 1,25(OH) 2 D 3 IN THE SKIN
A. Wnt Signaling in the Epidermis
The Wnt/β-catenin signaling pathway controls stem cell differentiation in the skin [143, 144] .
β-Catenin transcriptional activity promotes differentiation of the hair follicle lineages in embryonic and adult epidermis and, in certain circumstances, can expand the stem cell compartment [145, 146] . In contrast, β-catenin inhibits sebaceous gland differentiation [143, 147] and actively suppresses interfollicular epidermis differentiation in developing skin [145, 146] . Sonic hedgehog and Jagged-1, ligands of the Hedgehog and Notch signaling pathways, respectively, are β-catenin target genes in the epidermis and both pathways act downstream of β-catenin to induce stem cell expansion and follicle formation [148, 149] .
Consistent with the relation between aberrant Wnt signaling and cancer, deletion of β-catenin renders the epidermis resistant to chemically-induced tumors [150] . Moreover, prolonged activation of β-catenin in transgenic mice is sufficient to induce benign hair follicular tumors (pilomatricomas and trichofolliculomas) [151] , which regress when the pathway is no longer active [147] . Interestingly, human pilomatricomas have been found to harbor activating β-catenin mutations [152] .
B. The Vitamin D Receptor Mediates Wnt/β-Catenin Signaling in the Epidermis
VDR is essential for adult epidermal homeostasis [153] and mutations in the VDR gene in humans result in familial 1,25(OH) 2 D 3 -resistant rickets, which can be associated with alopecia [154] . In vivo, the expression of a mutant Vdr that can bind β-catenin but not 1,25(OH) 2 D 3 rescues alopecia in Vdr null mice, demonstrating ligand-independent functions of VDR in the skin [155] . Vdr null mice fail to undergo the first postnatal hair cycle; instead, the hair follicles are converted to cysts of interfollicular epidermis. Two independent groups have shown that the absence of Vdr impairs Wnt/-catenin signaling in keratinocytes and leads to alopecia [156, 157] . Cianferotti and cols. reported that Vdr ablation results in gradual depletion of the hair follicle stem cell pool which correlated with a failure of β-catenin to induce proliferation [156] . In contrast, Pálmer and cols. [158] defend that the degeneration of Vdr null follicles does not reflect a loss of follicle stem cells. Alternatively, they suggest that the failure to maintain the hair follicle may represent an inability of the stem cells to migrate along the follicle [158] . These authors also found that many genes that are upregulated by active β-catenin contain vitamin D response elements and that several of them are induced independently of TCF/LEF. They conclude that unliganded VDR is a Wnt effector and that β-catenin acts as VDR coactivator in epidermal keratinocytes [157] . For these researchers, the primary role of the VDR/β-catenin interaction in the skin is to promote the transcription of genes associated with differentiation of the hair follicle lineages. Although these genes are 
